Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14995938 | 0.74 | RAPGEF4 (0.55) | RAPGEF4 | |
| SCHEMBL29196018 | 0.71 | RAPGEF4 (0.50) | RAPGEF4 | |
| SCHEMBL4084555 | 0.69 | RAPGEF4 (0.35) | RAPGEF4 | |
| SCHEMBL4557600 | 0.67 | CYP3A4 (0.35) | RAPGEF4 | |
| SCHEMBL9643643 | 0.67 | RAPGEF4 (0.33) | RAPGEF4 | |
| Hydrochloric Acid SCHEMBL28693065 | 0.65 | RAPGEF4 (0.32) | RAPGEF4 | |
| SCHEMBL2633660 | 0.63 | ALDH1A1 (0.59) | TUBB1 | |
| SCHEMBL5566891 | 0.63 | ACHE (0.43) | TUBB1 | |
| SCHEMBL120101 | 0.62 | TSHR (0.39) | RAPGEF4 | |
| SCHEMBL21459249 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158802-A1 | MRNA TREATMENT NANOPARTICLES | MEDICI THERAPEUTICS, INC. | 2024-05-16 | — | — | US | disclosed |
| US-11879126-B2 | MRNA treatment nanoparticles | NUTCRACKER THERAPEUTICS, INC. (US) | 2024-01-23 | — | — | US | disclosed |
| US-20230193288-A1 | MRNA TREATMENT NANOPARTICLES | MEDICI THERAPEUTICS, INC. | 2023-06-22 | — | — | US | disclosed |
| EP-4139044-A1 | MRNA TREATMENT NANOPARTICLES | Nutcracker Therapeutics, Inc. (US) | 2023-03-01 | — | — | EP | disclosed |
| WO-2021216647-A1 | MRNA TREATMENT NANOPARTICLES | NUTCRACKER THERAPEUTICS, INC. (US) | 2021-10-28 | — | — | WO | disclosed |